IGF1R and cervical carcinoma: We demonstrated that the engineered ubiquitin ligase PTB-U-box can promote the ubiquitination and degradation of IGF-1R and IR, and thus effectively inhibit in vitro and in vivo malignant behaviors of liver cancer HepG2 and cervical cancer HeLa cells that over-express IGF-1R and IR.